abstract |
The invention provides a crystal form of anti-hyperuricemia drug 2-(3-cyano-4-isooxyphenyl)-4-methyl-5-thiazole formic acid and a method for preparing the same. The method for preparing the crystal form mainly comprises the following steps: heating up and dissolving the 2-(3-cyano-4-isooxyphenyl)-4-methyl-5-thiazole formic acid in ethyl acetate, and cooling down the solution for recrystallizing the solution to obtain the crystal form. The crystal form has better dissolution degree and stability. |